AAAAAA

   
Results: 1-11 |
Results: 11
HAPTOGLOBIN POLYMORPHISM, IRON-METABOLISM AND MORTALITY IN HIV-INFECTION
Authors: DELANGHE JR LANGLOIS MR BOELAERT JR VANACKER J VANWANZEELE F VANDERGROEN G HEMMER R VERHOFSTEDE C DEBUYZERE M DEBACQUER D ARENDT V PLUM J
Citation: Jr. Delanghe et al., HAPTOGLOBIN POLYMORPHISM, IRON-METABOLISM AND MORTALITY IN HIV-INFECTION, AIDS, 12(9), 1998, pp. 1027-1032
DRUG-RESISTANCE MUTATIONS AS PREDICTORS OF PHENOTYPIC ZIDOVUDINE RESISTANCE IN HIV-1 INFECTION
Authors: CHEN P SCHMIT JC ARENDT V PLESSERIA JM LAMBERT C FONTAINE E KIRPACH P NINOVE D SCHNEIDER F HEMMER R
Citation: P. Chen et al., DRUG-RESISTANCE MUTATIONS AS PREDICTORS OF PHENOTYPIC ZIDOVUDINE RESISTANCE IN HIV-1 INFECTION, AIDS, 11(12), 1997, pp. 1528-1529
COMPARATIVE ACTIVITY OF PIPERACILLIN TAZOBACTAM AGAINST 5625 ISOLATESFROM HOSPITALIZED-PATIENTS/
Authors: VERBIST L VERHAEGEN J WOUTERS C VANDENHOVEN G ALLEMEERSCH D BARDIAU C BELLON A CARPENTIER M COLAERT J CROKAERT F DHONT N DEBRAUW W DECKERS P DECLERCQ P DEDISTE A DELMEE M DEMOL P DEMUELENAERE G DEPUYDT H DESMARETS JM DEWEER M DIERICK J FAMEREE D GARRINO MG GLUPCZYNSKI I GOFFINET P GONISSEN V GOOSSENS H HEMMER R HUBRECHTS JM LECLERCQ M LIEVENS P MAES P MAGERMAN K MARCHAL JF MARTENS F MELIN P MERTENS HJ MERTENS A MEUNIER F PAUQUAY F PEPERSACK F POTVLIEGE C SCHNEIDER F SIMON G SIMON A SMEKENS J TRIGOUX J URSI JP VAEL C VANDELANOITTE P VANDENABEELE AM VANDENBULCKE A VANDEVIJVERE M VANLANDUYT HW VANNIMMEN L VANNOYEN R VERMAELEN K VINCKE G VUYE A WAUTELET MJ
Citation: L. Verbist et al., COMPARATIVE ACTIVITY OF PIPERACILLIN TAZOBACTAM AGAINST 5625 ISOLATESFROM HOSPITALIZED-PATIENTS/, Journal of antimicrobial chemotherapy, 37(2), 1996, pp. 285-293
EPIDEMIOLOGY OF CRYPTOSPORIDIOSIS AMONG EUROPEAN AIDS PATIENTS
Authors: PEDERSEN C DANNER S LAZZARIN A GLAUSER MP WEBER R KATLAMA C BARTON SE LUNDGREN JD CLUMECK N DEWIT S SOMMEREIJNS B NIELSEN JO NIELSEN T JENSEN G SKINHOJ P BENTSEN K GERSTOFT J MELBYE M RANKI A VALLE SL BERLUREAU P DIETRICH M SCHWANDER S GOEBEL FD KOSMIDIS J STERGIOU G GOUZIA T PAPADOPOULOS A BANHEGYI D MULCAHY F YUST I BENISHAI Z BENTWICH Z SACKS T MAAYAN S VELLA S CHIESI A ANCARANI F SCALISE G BERTAGGIA A FRANCAVILLA E CALONGHI G EMILIA R CARGNEL A ARLOTTI M CIAMMARUGHI R RIMINI I COLOMBA A DELALLA F FASSIO P FERLINI A FIACCADORI F PASETTI G GIANNELLI F GRILLONE W MONFORTE AD MIGNANI E ANDREA S NUNNARI A ORTONA L PANICHI G PAULUZZI S PIERSANTELLI N RANIERI S RICCIARDIELLO P ROSCIOLI B SORANZO M HEMMER R REISS P ANTUNES F GONZALEZLAHOZ J POLO R CLOTET B GATELL J BUIRA E MIRO J PEHRSON P LUTHY R LEDERGERBER B OLSSON C GLAUSER M HIRSCHEL B JOHNSON A HAWKES S PHILLIPS A BARTON S MORCINEK J PINCHING A COLEMAN D GJORUP I NIEPORT C TEGLBJAERG L THORNVAL A
Citation: C. Pedersen et al., EPIDEMIOLOGY OF CRYPTOSPORIDIOSIS AMONG EUROPEAN AIDS PATIENTS, Genitourinary medicine, 72(2), 1996, pp. 128-131
COMPARATIVE PATHOGENESIS OF HUMAN WA1 AND BABESIA-MICROTI ISOLATES INA SYRIAN-HAMSTER MODEL
Authors: WOZNIAK EJ LOWENSTINE LJ HEMMER R ROBINSON T CONRAD PA
Citation: Ej. Wozniak et al., COMPARATIVE PATHOGENESIS OF HUMAN WA1 AND BABESIA-MICROTI ISOLATES INA SYRIAN-HAMSTER MODEL, Laboratory animal science, 46(5), 1996, pp. 507-515
FACTORS ASSOCIATED WITH THE DEVELOPMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA IN 5,025 EUROPEAN PATIENTS WITH AIDS
Authors: LUNDGREN JD BARTON SE LAZZARIN A DANNER S GOEBEL FD PEHRSON P MULCAHY F KOSMIDIS J PEDERSEN C PHILLIPS AN CLUMECK N DEWIT S SOMMEREIJNS B NIELSEN JO LUNDGREN J NIELSEN T JENSEN G SKINHOJ P BENTSEN K GERSTOFT J MELBYE M RANKI A VALLE SL KATLAMA C BERLUREAU P DIETRICH M SCHWANDER S PAPADOPOULOS A BANHEGYI D YUST I BENISHAI Z BENTWICH Z SACKS T MAAYAN S VELLA S CHIESI A ANCARANI F SCALISE G BERTAGGIA A FRANCAVILLA E CALONGHI G CARGNEL A ARLOTTI M CIAMMARUGHI R COLOMBA A DELALLA F FASSIO P FERLINI A FIACCADORI F PASETTI G GIANNELLI F GRILLONE W DARMINIO A SACCO L MIGNANI E NUNNARI A ORTONA L PANICHI G PAULUZZI S PIERSANTELLI N RANIERI S RICCIARDIELLO P ROSCIOLI B SORANZO M HEMMER R BLOEMKOLK D ANTUNES F PROENCA R GONZALEZLAHOZ J MARTINEZBLANCO L CLOTET B GATELL J BUIRA E MIRO J LUTHY R LEDERGERBER B OLSSON C GLAUSER M HIRSCHEL B JOHNSON A HAWKES S PHILLIPS A BARTON S MORCINEK J PINCHING A COLEMAN D GJORUP I NIELSEN J NIEPORT C TEGLBJAERG L THORNVAL A
Citation: Jd. Lundgren et al., FACTORS ASSOCIATED WITH THE DEVELOPMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA IN 5,025 EUROPEAN PATIENTS WITH AIDS, Clinical infectious diseases, 21(1), 1995, pp. 106-113
PIPERACILLIN-TAZOBACTAM PLUS AMIKACIN VERSUS CEFTAZIDIME PLUS AMIKACIN AS EMPIRIC THERAPY FOR FEVER IN GRANULOCYTOPENIC PATIENTS WITH CANCER
Authors: COMETTA A ZINNER S DEBOCK R CALANDRA T GAYA H KLASTERSKY J LANGENAEKEN J PAESMANS M VISCOLI C GLAUSER MP GIBSON B SANZ M HANN IM FOLLATH F FATIO R FERSTER A VANHOOF A VANLANDUYT H ARENDT V HEMMER R PEETERMANS M PADMOS A SEITANIDES B HATZIYANNI M LOPEZ A PORCELLINI A GREK V CABALLERO D TOGNI P GALLAGHER JG GARAVENTA A MASSIMO L SUGAR A LEGRAND JC OPPENHEIM B PETRIKKOS G BEYTOUT J NIKOSKELAINEN J SHAPIRO M ESTAVOYER JM KERN W
Citation: A. Cometta et al., PIPERACILLIN-TAZOBACTAM PLUS AMIKACIN VERSUS CEFTAZIDIME PLUS AMIKACIN AS EMPIRIC THERAPY FOR FEVER IN GRANULOCYTOPENIC PATIENTS WITH CANCER, Antimicrobial agents and chemotherapy, 39(2), 1995, pp. 445-452
CHANGES IN SURVIVAL OVER TIME AFTER A FIRST EPISODE OF PNEUMOCYSTIS-CARINII PNEUMONIA FOR EUROPEAN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME
Authors: LUNDGREN JD BARTON SE KATLAMA C LEDERGERBER B GONZALEZLAHOZ J PINCHING AJ PROENCA R HEMMER R PEDERSEN C PHILLIPS AN
Citation: Jd. Lundgren et al., CHANGES IN SURVIVAL OVER TIME AFTER A FIRST EPISODE OF PNEUMOCYSTIS-CARINII PNEUMONIA FOR EUROPEAN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME, Archives of internal medicine, 155(8), 1995, pp. 822-828
SURVIVAL DIFFERENCES IN EUROPEAN PATIENTS WITH AIDS, 1979-89
Authors: LUNDGREN JD PEDERSEN C CLUMECK N GATELL JM JOHNSON AM LEDERGERBER B VELLA S PHILLIPS A NIELSEN JO DEWIT S SOMMEREIJNS B NIELSEN T JENSEN G SKINHOJ P BENTSEN K GERSTOFT J MELBYE M RANKI A VALLE SL KATLAMA C BERLUREAU P DIETRICH M SCHWANDER S GOEBEL FD KOSMIDIS J STERGIOU G GOUZIA T PAPADOPOULOS A BANHEGYI D MULCAHY F YUST I BENISHAI Z BENTWICH Z SACKS T MAAYAN S CHIESI A ANCARANI F SCALISE G BERTAGGIA A FRANCAVILLA E CALONGHI G CARGNEL A ARLOTTI M CIAMMARUGHI R COLOMBA A DELALLA F FASSIO P FERLINI A FIACCADORI F PASETTI G GIANNELLI F GRILLONE W LAZZARIN A MONFORTE AD MIGNANI E NUNNARI A ORTONA L PANICHI G PAULUZZI S PIERSANTELLI N RANIERI S RICCIARDIELLO P ROSCIOLI B SORANZO M HEMMER R DANNER S ANTUNES F PROENCA R GONZALEZLAHOZ J MARTINEZBLANCO L CLOTET B BUIRA E MIRO J PEHRSON P LUTHY R OLSSON C GLAUSER M HIRSCHEL B HAWKES S BARTON S MORCINEK J PINCHING A COLEMAN D
Citation: Jd. Lundgren et al., SURVIVAL DIFFERENCES IN EUROPEAN PATIENTS WITH AIDS, 1979-89, BMJ. British medical journal, 308(6936), 1994, pp. 1068-1073
COMPARISON OF LONG-TERM PROGNOSIS OF PATIENTS WITH AIDS TREATED AND NOT TREATED WITH ZIDOVUDINE
Authors: LUNDGREN JD PHILLIPS AN PEDERSEN C CLUMECK N GATELL JM JOHNSON AM LEDERGERBER B VELLA S NIELSEN JO DEWIT S SOMMEREIJNS B NIELSEN T JENSEN G SKINHOJ P BENTSEN K GERSTOFT J MELBYE M RANKI A VALLE SL KATLAMA C BERLUREAU P DIETRICH M SCHWANDER S GOEBEL FD KOSMIDIS J STERGIOU G GOUZIA T PAPADOPOULOS A BANHEGYI D MULCAHY F YUST I BENISHAI Z BENTWICH Z SACKS T MAAYAN S CHIESI A ANCARANI F SCALISE G BERTAGGIA A FRANCAVILLA E CALONGHI G CARGNEL A ARLOTTI M CIAMMARUGHI R COLOMBA A DELALLA F FASSIO P FERLINI A FIACCADORI F PASETTI G GIANNELLI F GRILLONE W LAZZARIN A MONFORTE AD MIGNANI E NUNNARI A ORTONA L PANICHI G PAULUZZI S PIERSANTELLI N RANIERI S RICCIARDIELLO P ROSCIOLI B SORANZO M HEMMER R DANNER S BLOEMKOLK D ANTUNES F PROENCA R GONZALEZLAHOZ J MARTINEZBLANCO L CLOTET B GATELL J BUIRA E MIRO J PEHRSON P LUTHY R LEDERGERBER B OLSSON K GLAUSER M HIRSCHEL B JOHNSON A HAWKES S PHILLIPS A BARTON S MORCINEK J PINCHING A COLEMAN D GJPRUP I NIELSEN J NIEPORT C TEGLBJAERG L THORNVAL A
Citation: Jd. Lundgren et al., COMPARISON OF LONG-TERM PROGNOSIS OF PATIENTS WITH AIDS TREATED AND NOT TREATED WITH ZIDOVUDINE, JAMA, the journal of the American Medical Association, 271(14), 1994, pp. 1088-1092
EFFICACY AND TOXICITY OF SINGLE DAILY DOSES OF AMIKACIN AND CEFTRIAXONE VERSUS MULTIPLE DAILY DOSES OF AMIKACIN AND CEFTAZIDIME FOR INFECTION IN PATIENTS WITH CANCER AND GRANULOCYTOPENIA
Authors: CALANDRA T ZINNER SH VISCOLI C DEBOCK R GAYA H MEUNIER F KLASTERSKY J GLAUSER MP NINOVE D LANGENAEKEN J PAESMANS M GALAZZO M GIDDEY M BILLE J HADJDJILANI A MASSIMO L MORONI C CASTAGNOLA E SANZ M FERSTER A DEBOCK R MEUNIER F KLASTERSKY J PADMOS A GALLAGHER J COMETTA A GLAUSER MP CALANDRA T LOPEZ A MARTINEZDALMAU A POGLIANI E HEMMER R DICATO M RIES F PORCELLINI A LEGRAND JC PORCELLINI A ESTAVOYER JM FOLLATH F SEITANIDES B ZINNER S BROWNE M NIKOSKELAINEN J ROSSI M MASERA G
Citation: T. Calandra et al., EFFICACY AND TOXICITY OF SINGLE DAILY DOSES OF AMIKACIN AND CEFTRIAXONE VERSUS MULTIPLE DAILY DOSES OF AMIKACIN AND CEFTAZIDIME FOR INFECTION IN PATIENTS WITH CANCER AND GRANULOCYTOPENIA, Annals of internal medicine, 119(7), 1993, pp. 584-593
Risultati: 1-11 |